polymerase PB2 inhibitors (Sichuan University/Nankai University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepolymerase PB2 inhibitors (Sichuan University/Nankai University)
Drug Alias NameDiscovery of S-(S-fluoro-l H-pyrrolo [2,3-b] pyridin-3-yl)pyrazin-2C1 H-on e derivatives as new potent PB2 inhibitors
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase basic protein 2 inhibitors
TargetsPolymerase basic protein 2
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesSichuan UniversityNankai University
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A